Samsung Bioepis Co., Ltd. announced today new data supporting consistent efficacy of SB16 (OBODENCE ®1), a biosimilar to Prolia 2 (denosumab) across patient subgroups compared to the reference ...
Subgroup analysis from Phase 3 study demonstrates consistent efficacy of SB16 across key patient populations - Results reinforce the totality-of-evidence supporting SB16 biosimilarity Samsung Bioepis ...
Laura Joseph. You’ve worked across telecoms, banking and the Post Office before joining Tesco Mobile as chief customer ...
DT is expanding the scope of its 5G network slicing portfolio to include video calling and has introduced a new brand name: ...
Leading Market Intelligence Program Honors Innovation in Analytics, AI, DataOps and Next-Generation Data Technologies ...
Every iPhone Fold rumour so far, from release date to specs and price - After years of waiting, the tech giant’s first ...
iPhone 18 Pro leak hints at new deep red colour – plus all the rumours to know - There could also be a smaller dynamic island ...
Go to Amazon to buy the DJI Mini 4K Drone for $209, down from its usual price of $299. That’s a $90 discount and 30% off. The ...
Jonny Clayton has delivered a message to Luke Littler after toppling the world No.1 and extending his lead at the top of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results